Researchers from the University of Michigan and the University of California San Diego have published a groundbreaking study identifying the…
Read More
Rising Therapy-Related Leukemia Rates Signal New Testing Demands for Clinical Labs
The landscape of cancer care is undergoing a profound transformation, marked by significant advancements in diagnostics and therapeutics that have…
Read More
Breast cancers that disseminate to bone marrow acquire aggressive phenotypes through CX43-related tumor-stroma tunnels.
This fundamental discovery, detailed in a collaborative study by researchers from the University of Michigan and the University of California…
Read More
Deciphering the Inflammatory Niche: How Bone Marrow Microenvironments Drive the Progression of Pre-Leukemic States and Age-Related Blood Disorders
Every second, the human bone marrow performs a biological feat of staggering proportions, generating millions of fresh blood and immune…
Read More
Rising Therapy-Related Leukemia Rates Signal New Testing Demands for Clinical Labs
The landscape of cancer care is undergoing a profound transformation, marked by significant advancements in treatment modalities that have dramatically…
Read More
Groundbreaking Nasal Spray Delivers Therapeutic miRNA to Combat Neuroinflammaging and Age-Related Cognitive Decline
Researchers at the Texas A&M University Naresh K. Vashisht College of Medicine (TX, USA), under the leadership of Ashok Shetty,…
Read More
Rising Therapy-Related Leukemia Rates Signal New Testing Demands for Clinical Labs
A new population-based study, published in CANCER, a journal of the American Cancer Society, has brought into sharp focus a…
Read More
Rubedo Life Sciences Pivots from Cosmetic Enhancement to Biological Rejuvenation with Senescent Cell Clearance for Age-Related Skin Conditions
Dr. Frederick Beddingfield III, a seasoned pharmaceutical executive known for his instrumental role in scaling Botox into a multi-billion-dollar franchise…
Read More
Breast cancers that disseminate to bone marrow acquire aggressive phenotypes through CX43-related tumor-stroma tunnels
The persistence of estrogen receptor-positive (ER+) breast cancer remains one of the most formidable challenges in modern oncology, as patients…
Read More
Breast cancers that disseminate to bone marrow acquire aggressive phenotypes through CX43-related tumor-stroma tunnels
The phenomenon of cancer recurrence remains one of the most significant challenges in modern oncology, particularly in the context of…
Read More
